CSIMarket
 
Resmed Inc   (NYSE: RMD)
 
Price: $228.3500 $-0.84 -0.367%
Day's High: $228.49000549316406 Week Perf: -4.89 %
Day's Low: $ 225.16 30 Day Perf: 2.29 %
Volume (M): 837,607 52 Wk High: $ 284.87
Volume (M$): $ 0 52 Wk Avg: $235.98
Open: $225.91 52 Wk Low: $180.27



 Market Capitalization (Millions $) 33,351
 Shares Outstanding (Millions) 146
 Employees 11,370
 Revenues (TTM) (Millions $) 5,628
 Net Income (TTM) (Millions $) 1,523
 Cash Flow (TTM) (Millions $) 451
 Capital Exp. (TTM) (Millions $) 159

Business Description


Company Profile: ResMed Inc.

Overview:
ResMed Inc. is a global leader in the development, manufacturing, and distribution of innovative products and solutions for sleep apnea and other respiratory conditions. Established in 1989 in Sydney, Australia, ResMed has evolved into a multinational corporation with a presence in over 140 countries.

Products and Solutions:
ResMed specializes in designing and producing high-quality medical devices, primarily focused on treating sleep disorders such as obstructive sleep apnea. Key products include:

- Continuous Positive Airway Pressure (CPAP) Machines: Devices that provide air pressure to keep the airways open during sleep.
- Masks and Accessories: A range of masks designed for comfort and effectiveness, complemented by essential accessories.
- Digital Health Technologies: Cloud-based software solutions that enable healthcare providers to remotely monitor and manage patient conditions.

ResMed’s proprietary technology is anchored in advanced ventilation algorithms that utilize sensors and data analytics. This technology customizes treatment plans based on individual patient needs, automatically adjusting air pressure to ensure precise treatment throughout the night, ultimately leading to better sleep and enhanced health outcomes.

Research and Development:
The company is devoted to advancing the field of respiratory medicine through substantial investments in research and development. ResMed conducts clinical studies and collaborates with leading healthcare providers and research institutions globally. Additionally, the company works with patient advocacy groups to enhance awareness of sleep disorders, promote patient education, and encourage adherence to treatment protocols.

Headquarters and Global Presence:
ResMeds corporate headquarters are located in San Diego, California. It operates additional facilities throughout Australia, Europe, and the Asia-Pacific region, allowing for comprehensive support and distribution of its products internationally.

Recognition and Performance:
ResMed has garnered accolades for product innovation, sustainability initiatives, and corporate social responsibility. The company is publicly traded on major stock exchanges, including the New York Stock Exchange (NYSE) and the Australian Securities Exchange (ASX).

Conclusion:
Through its commitment to innovation, patient-centric solutions, and global reach, ResMed Inc. continues to impact the field of respiratory health, improving the lives of patients suffering from sleep disorders and contributing to advancements in respiratory medicine.


   Company Address: 9001 Spectrum Center Blvd. San Diego 92123 CA
   Company Phone Number: 836-5000   Stock Exchange / Ticker: NYSE RMD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ELMD   -5.41%    
INGN   -1.45%    
NIMU        10% 
STXS   -4.14%    
VVOS   -17.16%    
AHCO        12.09% 
• View Complete Report
   



Product Service News

Resmed Inc Pioneers Sleep Health Innovation with New Institute, Surges Ahead of Competitors in a Challenging Market...

Published Thu, Sep 4 2025 3:34 AM UTC

In a pioneering move to elevate sleep health on a global stage, Resmed Inc has announced the launch of its cutting-edge Sleep Institute during the prestigious World Sleep Congress 2025. This innovative venture, officially known as the Global Clinical Insights Initiative, aims to foster advancements in sleep health care. As the company asserts its leadership role in the indus...

Product Service News

ResMeds Innovative Leap Simplifying Sleep Apnea Solutions with New Products and Safety Enhancements

Published Thu, Apr 3 2025 2:39 PM UTC

In the fast-evolving realm of healthcare technology, ResMed continues to shine as a leader in developing advanced solutions for sleep apnea, a condition affecting millions globally. Recently, three significant announcements highlighted ResMed s commitment to enhancing patient care through innovation, ease of use, and safety. 1. Launch of NightOwl: A Game-Changer for Home Sle...

Product Service News

ResMed Introduces Innovative Fabric CPAP Mask for Improved Sleep Health

Published Mon, Sep 30 2024 12:11 PM UTC

In a significant development for sleep apnea treatment, ResMed Inc. (NYSE: RMD) has launched its first-ever fabric CPAP mask, a product that promises to enhance comfort and usability for individuals undergoing Continuous Positive Airway Pressure (CPAP) therapy. This innovative design aims to make it easier for patients to adhere to their prescribed treatment and, in turn, im...

Management Announcement

ResMeds Forward-Thinking 2030 Strategy: A Robust Blueprint for Sustainable Growth and Shareholder Value

Published Mon, Sep 30 2024 8:05 PM UTC

In a significant move aimed at securing its position as a leader in the healthcare sector, ResMed (NYSE: RMD, ASX: RMD) unveiled its ambitious 2030 Strategy during an Investor Day event held in New York City on September 30, 2024. This new initiative is designed to drive growth, enhance profitability, and maximize shareholder returns, reflecting ResMed s commitment to innova...

Dividend

ResMed Inc. Reports Fourth Quarter Earnings Amidst Optimism Over Dividend Outlook

Published Thu, Aug 1 2024 8:05 PM UTC


On insert date of release, ResMed Inc. announced its financial results for the fourth quarter of fiscal year 2024, revealing a solid performance that reinforces the company s position in the healthcare sector. The webcast of ResMed’s conference call, where additional details and insights were discussed, is available for those interested at http://investor.resmed.com(h...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 21.91
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 5.93
Price to Sales (Expected) -
Price to Book 5.06
PEG (TTM) 2.29

Financial Strength Current
Quick Ratio 1.05
Working Capital Ratio 2.81
Leverage Ratio (MRQ) 0.36
Total Debt to Equity 0.14
Interest Coverage (TTM) 45.8
Debt Coverage (TTM) 3.13

Per Share Current
Earnings (TTM) 10.42 $
Revenues (TTM) 38.53 $
Cash Flow (TTM) 3.09 $
Cash 10.06 $
Book Value 45.09 $
Dividend (TTM) 2.39 $

Efficiency Current
Revenue per Employee (TTM) 495,002
Net Income per Employee (TTM) 133,975
Receivable Turnover Ratio (TTM) 5.8
Inventory Turnover Ratio (TTM) 2.33
Asset Turnover Ratio (TTM) 0.66

Profitability Ratios Current
Gross Margin (MRQ) 58.84 %
Operating Margin (MRQ) 30.66 %
Net Margin (MRQ) 26.2 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 20.64 %

Management Effectiveness Current
Return On Assets (TTM) 17.85 %
Return On Investment (TTM) 20.86 %
Return On Equity (TTM) 24.21 %
Dividend Yield 1.05 %
Pay out Ratio (TTM) 22.94 %



Resmed Inc's Segments
Sleep and Breathing Health    340.08 % of total Revenue
Residential Care Software    46.17 % of total Revenue
Devices    76.83 % of total Revenue
Masks and Other    39.09 % of total Revenue
United States    243.37 % of total Revenue
Non-US    142.89 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.